29 research outputs found

    PREPs Surveillance: Summary of Cognitive Interviews and Recommendations for PREPs Surveillance Measures

    Get PDF
    A review of existing research on population awareness of potentially reduced exposure tobacco products (PREPs) as well as results of cognitive interviews suggest that awareness of PREPs is quite low at this time, except in active test-markets. In order to monitor changes in awareness and perceptions of, and receptivity to these products over time, we have proposed using a set of questions as well as coding conventions that appear to result in reasonably accurate estimates of awareness of a particular group of products. The recommended items, which performed will in cognitive interviews, are presented in Appendix D of this report. It must be acknowledged that this report is limited by the need to restrict the number of respondents and by the fact that those included were of relatively high socio-economic status. Prior to any large scale use of these survey items, we recommend that further pre-tests be done using other survey modes (telephone and self-administered), and that an effort be made to include respondents with lower levels of education, and with greater cultural diversity

    PREPs Surveillance: Summary of Existing Survey Measures and Recommendations for Ongoing Efforts

    Get PDF
    Over the past decade or more, tobacco companies have introduced cigarettes with lower content of some toxins than regular and light cigarettes. These new cigarettes, referred to as a class as Potential Reduced Exposure Products (PREPs), have typically been introduced into test markets, not nationwide, which means they are not yet widely known or recognized by name or description by most consumers. However, the introduction of these products is of great concern to public health advocates, who do not believe that enough research, particularly long term research, has been done to know whether or not the PREPs, even if proven to have reduced toxins, actually present a reduced health risk. The fear in the public health community is that smokers who might have been motivated to quit may reverse those quit plans if they perceive an alternative, safer smoking option exists with the PREPs. Likewise, there is concern that former smokers could be tempted back to smoking and non-smokers could be tempted to initiate smoking if they too perceive that PREPs present lower health risks than other cigarettes. Having faced a similar situation with the introduction of ā€œlightā€ cigarettes ā€“ i.e. new product, insufficient research about its health implications -- public health officials are feeling cautious about PREPs and have called for development of a science to evaluate PREPs, as well as ongoing surveillance. In order to obtain as complete a set of existing measures as possible, we reviewed published literature on consumer reactions to PREPs and solicited input about ongoing studies from members of the project advisory group, members of the Harm Reduction Network, and other members of the tobacco research community. Appendix A is a list of studies we have included in the summary of current data on the subject of PREPs surveillance. Appendix B is the full listing of PREPs-related questions for each included study

    Tributes to Professor Edward Tomlinson

    Get PDF

    Tributes to Professor Garrett Power

    Get PDF

    Measuring Patient Experience During the Covid-19 Pandemic And Beyond

    Full text link
    Traditional patient experience measures may not fully capture the changes quickly transpiring in patient care due to COVID-19. This paper presents a questionnaire that could be a helpful starting point. The questionnaire addresses topics such as telehealth and non-visit-based care; care by non-physicians; discussion about end-of-life preferences, domestic violence, social health needs; and primary care follow-up after acute carehttps://deepblue.lib.umich.edu/bitstream/2027.42/155624/1/Patient survey development_AFM submission.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/155624/2/2019 CPC+ Beneficiary Survey (English).pdfDescription of Patient survey development_AFM submission.pdf : Main ArticleDescription of 2019 CPC+ Beneficiary Survey (English).pdf : Surve

    Tributes to Professor Alan Hornstein

    Get PDF
    Tributes to Professor Alan Hornstein upon his retirement from the University of Maryland School of Law

    Tributes to Professor Alice Brumbaugh

    Get PDF
    Tributes to Professor Alice Brumbaugh upon her retirement from the University of Maryland School of Law

    Surveillance indicators for potential reduced exposure products (PREPs): developing survey items to measure awareness

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Over the past decade, tobacco companies have introduced cigarettes and smokeless tobacco products (known as Potential Reduced Exposure Products, PREPs) with purportedly lower levels of some toxins than conventional cigarettes and smokeless products. It is essential that public health agencies monitor awareness, interest, use, and perceptions of these products so that their impact on population health can be detected at the earliest stages.</p> <p>Methods</p> <p>This paper reviews and critiques existing strategies for measuring <it>awareness </it>of PREPs from 16 published and unpublished studies. From these measures, we developed new surveillance items and subjected them to two rounds of cognitive testing, a common and accepted method for evaluating questionnaire wording.</p> <p>Results</p> <p>Our review suggests that high levels of awareness of PREPs reported in some studies are likely to be inaccurate. Two likely sources of inaccuracy in awareness measures were identified: 1) the tendency of respondents to misclassify "no additive" and "natural" cigarettes as PREPs and 2) the tendency of respondents to mistakenly report awareness as a result of confusion between PREPs brands and similarly named familiar products, for example, Eclipse chewing gum and Accord automobiles.</p> <p>Conclusion</p> <p>After evaluating new measures with cognitive interviews, we conclude that as of winter 2006, awareness of reduced exposure products among U.S. smokers was likely to be between 1% and 8%, with the higher estimates for some products occurring in test markets. Recommended measurement strategies for future surveys are presented.</p
    corecore